Related Experiment Video
Updated: Aug 14, 2026
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Langerhans cell histiocytosis
1Department of Pediatric Hematology-Oncology, Sophia Children's Hospital, Erasmus University Rotterdam, The Netherlands.
Insights
Understanding Langerhans cell histiocytosis (LCH) advanced with cell identification and diagnostic criteria. Modern imaging and data centralization improve clinical management and research for LCH.
Area of Science:
- Histiocytosis
- Immunology
- Cell Biology
Background:
- Langerhans cell histiocytosis (LCH) understanding has evolved significantly.
- Initial breakthroughs involved identifying proliferating cells within the Langerhans (dendritic) cell system.
- Defining diagnostic criteria marked another crucial advancement.
Purpose of the Study:
- To summarize key advancements in understanding and diagnosing Langerhans cell histiocytosis (LCH).
- To highlight the impact of modern imaging and data centralization on LCH clinical management.
- To establish a foundation for ongoing research into LCH etiology.
Main Methods:
- Ultrastructural studies for cell identification.
- Definition of morphologic, immunohistochemical, and clinical diagnostic criteria.
- Application of modern imaging techniques, particularly for brain and pituitary lesions.
Main Results:
- Proliferating cells in LCH identified as part of the Langerhans cell system.
- Established diagnostic criteria facilitate consistent LCH diagnosis.
- Advanced imaging reveals previously undetected lesions, improving understanding of disease extent.
- Centralized data facilitates comparison and coherent clinical/therapeutic strategies.
Conclusions:
- Advances in cell identification, diagnostics, and imaging have significantly improved LCH understanding and management.
- Standardized diagnostic criteria are essential for current clinical trials and laboratory research.
- Further research is warranted into the roles of the immune system, clonality, and cytokines in LCH etiology.
Abstract:
The first major stride toward understanding LCH was taken when ultrastructural studies identified the proliferating cells as part of the Langerhans (dendritic) cell system. Another step forward was the definition of the morphologic, immunohistochemical, and clinical criteria needed for the diagnosis of LCH. Meanwhile, modern imaging studies have disclosed lesions that were not previously visible, especially those in the brain and the pituitary gland. These advantages have had a major impact on clinical management by making it possible to compare data from different institutions and to centralize coherent clinical and therapeutic data. Moreover, the agreement concerning diagnostic criteria provides a solid foundation for current clinical trials and for laboratory research regarding the possible roles of the immune system, clonality, and cytokines in the etiology of LCH.
